Insider Selling: Delta 9 Cannabis Inc (CVE:NINE) Director Sells 80,000 Shares of Stock
Insider Selling: Delta 9 Cannabis Inc (CVE:NINE) Director Sells 80,000 Shares of Stock
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.Delta 9 Cannabis Inc (CVE:NINE – Get Rating) Director Hugh Housser Aird sold 80,000 shares of the business's stock in a transaction dated Friday, August 26th. The shares were sold at an average price of C$0.16, for a total value of C$13,112.00. Following the completion of the transaction, the director now owns 167,500 shares in the company, valued at approximately C$27,453.25.
德爾塔9號大麻公司(CVE：9-GET評級)董事休·豪塞爾·艾德在8月26日星期五的交易中出售了80,000股該公司股票。這些股票的平均價格為0.16加元，總價值為13,112.00加元。交易完成後，董事現在擁有該公司167,500股票，價值約27,453.25加元。
Hugh Housser Aird also recently made the following trade(s):
休·豪瑟·艾爾德最近還進行了以下交易：
- On Monday, August 22nd, Hugh Housser Aird sold 45,000 shares of Delta 9 Cannabis stock. The shares were sold at an average price of C$0.19, for a total value of C$8,338.50.
- 8月22日，星期一，休·豪澤航空公司出售了45,000股Delta 9大麻股票。這些股票的平均價格為0.19加元，總價值為8,338.50加元。
Delta 9 Cannabis Price Performance
Delta 9大麻的性價比
Delta 9 Cannabis stock opened at C$1.03 on Friday. The company has a debt-to-equity ratio of 33.00, a current ratio of 4.44 and a quick ratio of 2.04. The business has a 50 day simple moving average of C$1.03 and a 200-day simple moving average of C$1.03. Delta 9 Cannabis Inc has a 12 month low of C$0.92 and a 12 month high of C$2.35. The stock has a market capitalization of C$89.36 million and a PE ratio of 19.07.
Delta 9大麻股票週五開盤報1.03加元。該公司的債務權益比為33.00，流動比率為4.44，速動比率為2.04。該業務的50日簡單移動均線切入位在1.03加元，200日簡單移動均線切入位在1.03加元。Delta 9 Cannabis Inc.的12個月低點為0.92加元，12個月高位為2.35加元。該股市值為8936萬加元，市盈率為19.07倍。
Delta 9 Cannabis Company Profile
Delta 9大麻公司簡介
Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.
Delta 9大麻公司是一家綜合性大麻公司。該公司通過其子公司Delta 9 Bio-Tech Inc從事醫用大麻的生產。它主要提供大麻品種，以及啟動材料和支持服務，包括遺傳學(植物)、種植豆莢，以及向新的和現有的獲得許可的生產商提供諮詢服務。
Recommended Stories
推薦故事
- Could Nike Stock be Oversold, but Still Overvalued?
- Is Alcoa A Buy After Strong Q2 Results And More Share Buybacks?
- Will Royal Caribbean's Broadband Partnership Drive Revenue?
- Chip Gear Maker Entegris Has Potential, But Is It Buyable Now?
- DocuSign Has Important Issues to Address When it Reports Earnings
- 耐克股票會被超賣，但仍被高估嗎？
- 美國鋁業是在第二季度業績強勁和更多股票回購之後買入的嗎？
- 皇家加勒比的寬帶合作能否推動收入增長？
- 芯片設備製造商Entigis很有潛力，但它現在可以買下嗎？
- DocuSign在報告收益時有重要的問題需要解決
Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
接受Delta 9大麻日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Delta 9大麻和相關公司的最新新聞和分析師評級的每日簡要摘要。